Amsterdam Molecular : Progenika Receives CE Mark for First DNA Chip
- LPLchip(R) Rapidly and Precisely Detects Mutations Causing LPL Deficiency, a Cause of Acute Pancreatitis - LPLchip(R) Identifies Patients who Could Benefit From Gene Therapy, Such as AMT's Glybera(R), Currently Under Review for EU Approval Progenika Biopharma S.A., a pioneer in the field of personalized medicine, announced today that it has obtained the CE Mark allowing the sale in Europe of its LPLchip(R), the first DNA chip to detect mutations in the lipoprotein lipase (LPL) gene. This diagnostic tool rapidly diagnoses patients with complete and partial lipoprotein lipase [more...]
Date: 2010-09-27 08:58:46
Journal of Translational Medicine | Full text | cDNA targets ...
Yet, gene expression profiling of peripheral whole blood has yet to be employed broadly. With the proliferation of whole genome analysis techniques, and their potential utility as both prognostic and diagnostic tools, there is a growing need to utilize readily available peripheral blood for techniques such as SNP analysis, copy number variation analysis and genome-wide gene expression. Even though peripheral whole blood is one of the most easily accessed tissues for whole genome gene expression profiling, there are a number of technical challenges. The first is mRNA stabilization and [more...]
Date: 2010-09-25 00:00:00
Scientist Develops New, Innovative Methods For Characterizing ...
Scientist Develops New, Innovative Methods For Characterizing Proteins - Science -Using a combination of high-powered computers and advanced experimental magnetic resonance data, a Florida State University biophysical chemist has ... Direct -to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the [more...]
Date: 2010-10-12 21:49:02
Illumina to Announce Third Quarter 2010 Financial Results on ...
We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare. [more...]
Date: 2010-10-13 04:08:35
Large Study Shows Females Are Equal To Males In Math Skills - Science
Large Study Shows Females Are Equal To Males In Math Skills - Science -The mathematical skills of boys and girls, as well as men and women, are substantially equal, according to a new examination of existing studies in the current ... Direct-to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the [more...]
Date: 2010-10-12 22:20:28
Ovarian Cancer Diagnostics | Ovaire
DNA testing reagents for cancer CTC Test markets Biochip Innovations New companies with new approaches "Laggards" Companies that have not met expectations Protein important molecular markers used in tissue staining Biomarkers under investigation Mergers and Acquisitions Status of pharmacogenomic tests Microarrays Markets in clinical laboratories The lists of suppliers and main products Unmet market needs This report includes market analysis of the following tests: The Profile Cancer CTC, fecal occult blood, PSA, H. pylori, IHC, ISH, and evidence of specific cancers: Bladder [more...]
Date: 2010-10-11 18:38:23